People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Coaxia Inc | — | Biotechnology | Series B | $40.0M | $893.0M | 2009 |
Richard S. Schallhorn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard S. Schallhorn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Denise Barbut | 1 | 9 |
| Brent Ahrens | 1 | 7 |
| James Bullock | 1 | 6 |
| ANTOINE PAPIERNIK | 1 | 6 |
| Peter Shagory | 1 | 5 |
| B. KRISTINE JOHNSON | 1 | 5 |
| Andrew M. Weiss | 1 | 3 |
| Gordie Nye | 1 | 2 |
| Antoine S. Papiernik | 1 | 1 |
| Lorinda L. Austin | 1 | 1 |
| Sharon D. Kvistad | 1 | 1 |
| Shelby S. Hautman | 1 | 1 |
| Peter Kristine Shagory | 1 | 1 |
| Joshua S. Resnick | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.